Spyre Therapeutics Plans $350M Stock Offering, Shares Fall
Shares of Spyre Therapeutics declined 12% to $81.83 after the company announced plans to sell $350 million worth of stock in a public offering.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.